Chemoinformaics analysis of trans-5-O-(4-coumaroyl)-D-quinic acid
| Molecular Weight | 338.312 | nRot | 4 |
| Heavy Atom Molecular Weight | 320.168 | nRig | 20 |
| Exact Molecular Weight | 338.1 | nRing | 2 |
| Solubility: LogS | -6.945 | nHRing | 0 |
| Solubility: LogP | 7.312 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 45.1383 |
| nHD | 5 | BPOL | 21.5297 |
| QED | 0.467 |
| Synth | 4.478 |
| Natural Product Likeliness | 2.96 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.881 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.81 |
| MDCK | 0.00000841 |
| BBB | 0.657 |
| PPB | 0.965602 |
| VDSS | 2.778 |
| FU | 0.0121714 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.432 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.947 |
| CYP2c9-inh | 0.094 |
| CYP2c9-sub | 0.805 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.634 |
| CYP3a4-inh | 0.168 |
| CYP3a4-sub | 0.562 |
| CL | 14.677 |
| T12 | 0.013 |
| hERG | 0.026 |
| Ames | 0.049 |
| ROA | 0.106 |
| SkinSen | 0.135 |
| Carcinogencity | 0.021 |
| EI | 0.01 |
| Respiratory | 0.691 |
| NR-Aromatase | 0.031 |
| Antiviral | Yes |
| Prediction | 0.789318 |